Read more

July 25, 2021
3 min watch
Save

VIDEO: Waring discusses phase 3 results for presbyopia drop

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

LAS VEGAS — In this video perspective from the ASCRS meeting, George O. Waring IV, MD, FACS, discusses phase 3 data from the GEMINI 1 study investigating AGN-190584 (pilocarpine 1.25%, Allergan) for the treatment of presbyopia.